One of the most critical scientific questions in TB today is the optimal combination of new and repurposed drugs for the treatment of extensively drug-resistant, pre- extensively drug-resistant, and hard-to-treat multidrug-resistant TB (XDR-TB, pre-XDR-TB, MDR-TB). Тhe Global TB Community Advisory Board (TB CAB) has developed a ...

Today we begin the launch of “Ten years in public health 2007-2017” – a report that chronicles the evolution of global public health over the decade that I have served as Director-General at WHO. This series of chapters, which will be published over the next 6 ...

6 JUNE 2017 | GENEVA - New advice on which antibiotics to use for common infections and which to preserve for the most serious circumstances is among the additions to the WHO Model list of essential medicines for 2017. Other additions include medicines for HIV, ...

Planning for this year’s High Level Political Forum is starting to pick up. In this document you will find some basic information to ensure you are up to speed in the upcoming processes and deadlines. More information will be shared periodically. When: July 10-19 Where: UN Headquarters, ...

In May 2016, the World Health Assembly endorsed the Global Health Sector Strategy (GHSS) on viral hepatitis 2016–2021. The GHSS calls for the elimination of viral hepatitis as a public health threat by 2030 (reducing new infections by 90% and mortality by 65%). This WHO Global ...

Civil society must remain vigilant to ensure that UN Member States take concrete action toward meeting targets to end AIDS by 2030 With this in mind, MSMGF has compiled video excerpts from the 2016 High Level Meeting on Ending AIDS (HLM) so we may continue to hold States ...

Some of the world’s largest funders of medical research and international non-governmental organizations today agreed on new standards that will require all clinical trials they fund or support to be registered and the results disclosed publicly. In a joint statement, the Indian Council of Medical Research, ...

As chronic hepatitis C virus (HCV) drug development approaches the end-game following the launch of the first pan-genotypic regimen Epclusa (; Gilead), recent and upcoming advances in chronic hepatitis B virus (HBV) treatment emerged as an important focus of the International Liver Conference (ILC) 2017, ...

UNAIDS’ vision of zero discrimination and ending AIDS by 2030 will only become a reality if the response to HIV reaches everyone, including lesbian, gay, bisexual, transgender and intersex (LGBTI) people. The International Day against Homophobia, Transphobia and Biphobia (IDAHOT), a worldwide celebration of sexual and ...

The European Medicines Agency’s (EMA) 2016 annual report published today focuses on the Agency’s key achievements in the areas of medicine evaluation, support to research and development of new and innovative treatments and the safety monitoring of medicines in real life. In 2016, the Agency recommended ...

A big data study of hepatitis C and more than 500 patients with the virus has opened the way for a better understanding of how the virus interacts with its human hosts. Researchers at the University of Oxford have for the first time developed a method ...

Face-to-face interventions work best A meta-analysis of studies of brief interventions to reduce HIV risk behaviour in HIV-negative gay men has concluded that there is evidence that such techniques did have a significant impact on the behaviours they were designed to change. It also found evidence that ...

Kaiser Family Foundation: The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) This updated fact sheet examines the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and its role in addressing global HIV/AIDS, including treatment and prevention targets, results, funding, and challenges (4/5). Source

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 308 of the “Global Fund Observer.” The newsletter features articles on various topics, including a news article on how the Trump administration’s budget proposals will impact the Global Fund, ...

UN Population Fund rejects state department’s claim that agency backs “coercive abortion or involuntary sterilisation”. The state department has announced it is ending US funding for the United Nation Population Fund (UNFPA), the international body’s agency focused on family planning as well as maternal and child ...

A new report from Public Citizen, the US-based consumer rights advocacy group, shows that the 20 largest pharmaceutical corporations are spending significantly less on research and development of new medicines than they are making in profits. The report shows that, on average for these top companies, ...

To mark World TB Day, 24 March 2017, the International Journal of Infectious Diseases published a special issue on TB. It highlights the Advances, Challenges and Opportunities in the ‘End TB’ Era through publishing 42 articles by a distinguished global authorship. The series of articles review progress ...

Implant could offer long-acting, removable form of prevention not currently available Chapel Hill, NC – Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system ...